Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110467555B details a chiral phosphoric acid catalyzed method for high-purity axial chiral aryl indoles, offering cost-effective routes for oncology drug development.
Patent CN107235967B reveals a green, mild synthesis of Tegafur using 5-fluorouracil and THF. Discover cost-effective manufacturing strategies for high-purity antineoplastic intermediates.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chain solutions.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply and simplified purification.
Patent CN109134351B details a novel synthesis of S-3-(4-aminophenyl)piperidine with >99% ee, offering cost-effective scalability for PARP inhibitor manufacturing.
Novel 5-step synthesis of Trilaciclib via CN114014864A. Offers high purity, mild conditions, and cost-effective manufacturing for global pharmaceutical supply chains.
Discover a novel asymmetric synthesis method for axially chiral indole-naphthalene compounds using chiral phosphoric acid. High enantioselectivity and mild conditions for API manufacturing.
Patent CN112480015B reveals a Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable production capabilities.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Patent CN108864110B reveals a novel organocatalytic route for anticancer naphthoquinopyrans, offering improved safety and scalability for pharmaceutical intermediate manufacturing.
Patent CN112920173A details a mild chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing potential.
Patent CN111892545A reveals a green photocatalytic route for quinoxalinones. Achieve high yields without transition metals, ensuring cost reduction in API manufacturing and reliable supply.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable supply chain solutions for API manufacturing.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for API manufacturing.
Patent CN115785122A details a novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines with high cytotoxicity, offering a scalable route for reliable pharmaceutical intermediate suppliers.
Patent CN103153956A details a novel route for kinase inhibitor intermediates using Suzuki-Miyaura coupling, offering enhanced safety and yield for pharmaceutical manufacturing.
Novel Pd-NHC catalyzed aminocarbonylation route for Tamibarotene. Reduces steps, improves yield, and lowers costs for reliable API intermediate supply.
Patent CN113045503B details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112920053A reveals a safer, high-yield route for chiral amines used in asthma and cancer drugs, offering significant cost reduction and supply chain reliability for API manufacturers.
Discover the novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines. A cost-effective, high-yield route for anticancer pharmaceutical intermediates with superior diastereoselectivity.